Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
-SEC 8K Filing
Rain Oncology Inc (NASDAQ: RAIN) has agreed to be acquired by Pathos AI Inc.
Pursuant and subject to the terms of the merger agreement, a subsidiary of Pathos will commence a tender offer to acquire all o...
Rain Oncology (NASDAQ:RAIN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.27)...
The Dow Jones closed slightly higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern...
Rain Oncology, Inc. (NASDAQ:RAIN) ("Rain") confirmed that it has received an unsolicited proposal from Tang Capital, LP...
On Tuesday, 647 companies set new 52-week lows.
Citigroup analyst Yigal Nochomovitz maintains Rain Oncology (NASDAQ:RAIN) with a Neutral and lowers the price target from $1...
